Discover opportunities months before the RFP drops
Learn more →Retrieving contract details... Hang tight!
See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
Premium
Clean & enrich your CRM automatically
Premium
Get complete source documentation & analysis
This contract includes 1 purchase order from Sep 9, 2022 to Sep 9, 2022
| Buyer | Vendor | Issued Date | Quantity |
|---|---|---|---|
| NIH NCI | Leidos Biomedical Research, Inc. | Sep 9, 2022 | 1 |
Full Purchase Intelligence Available
Get complete pricing, descriptions, and financial details for all 1 purchase orders
Unlock Full Details →See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
No public files available for this contract.
Contract documentation may be available through official government sources or agency portals. Starbridge can help you track down and retrieve these files.
RESEARCH, DEVELOPMENT, AND PRODUCTION TO SUPPORT CLINICAL TRIALS FOR HIV VACCINES.
Effective Date
Apr 12, 2022
Expires
Effective: Apr 12, 2022
Expires:
RESEARCH, DEVELOPMENT, AND PRODUCTION TO SUPPORT CLINICAL TRIALS FOR HIV VACCINES.
ActiveVRC HIV MAB-RESEARCH, DEVELOPMENT, AND PRODUCTION TO SUPPORT HIV MONOCLONAL ANTIBODY DEVELOPMENT - THE PRIMARY OBJECTIVE IS TO SUPPORT CELL LINE DEVELOPMENT, PROCESS DEVELOPMENT, ANALYTICAL DEVELOPMENT, REAGENT PRODUCTION, MANUFACTURING, AND TESTING
Effective Date
Feb 1, 2022
Expires
Expires:
VRC HIV MAB-RESEARCH, DEVELOPMENT, AND PRODUCTION TO SUPPORT HIV MONOCLONAL ANTIBODY DEVELOPMENT - THE PRIMARY OBJECTIVE IS TO SUPPORT CELL LINE DEVELOPMENT, PROCESS DEVELOPMENT, ANALYTICAL DEVELOPMENT, REAGENT PRODUCTION, MANUFACTURING, AND TESTING
ActiveDEVELOPMENT, PRODUCTION, AND DISSEMINATION OF NCI TOBACCO CONTROL MONOGRAPH
Effective Date
Jul 25, 2022
Expires
Effective: Jul 25, 2022
Expires:
DEVELOPMENT, PRODUCTION, AND DISSEMINATION OF NCI TOBACCO CONTROL MONOGRAPH
ActiveIGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF A CHIMPANZEE ADENOVIRUS HIV-1 VACCINE
Effective Date
Sep 15, 2016
Expires
Effective: Sep 15, 2016
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF A CHIMPANZEE ADENOVIRUS HIV-1 VACCINE
ActiveSee who's winning contracts, track spending trends, and identify your best opportunities before your competition.
Schedule Your Demo →Premium
Clean & enrich your CRM automatically
Premium
Get complete source documentation & analysis